Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Phibro Animal Health Affirms 2024 Adj. EPS And Net Sales Guidance

Author: Benzinga Newsdesk | February 07, 2024 06:21pm

We affirm our previously issued fiscal year 2024 guidance for the following measures:

  • Net sales of $980 million to $1.020 billion
  • Adjusted EBITDA of $106 million to $112 million
  • Adjusted net income of $42 million to $47 million, and
  • Adjusted diluted EPS of $1.04 to $1.16

Posted In: PAHC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist